Family C 7TM Receptor Dimerization and Activation

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 1, 2006-01 ,pp. : 7-16

Bentham Science Publishers

Access to resources Recommend Favorite

A Charge Pair Interaction Between Arg282 in Transmembrane Segment 7 and Asp341 in Transmembrane Segment 8 of hPepT1

By Kulkarni Ashutosh   Davies Daryl   Links Jennifer   Patel Leena   Lee Vincent   Haworth Ian  

Pharmaceutical Research, Vol. 24, Iss. 1, 2007-01 ,pp. : 66-72

Springer Publishing Company

Access to resources Recommend Favorite

The conformational switch in 7-transmembrane receptors: the muscarinic receptor paradigm

By Hulme E.C.   Lu Z.-L.   Ward S.D.C.   Allman K.   Curtis C.A.M.  

European Journal of Pharmacology, Vol. 375, Iss. 1, 1999-06 ,pp. : 247-260

Elsevier

Access to resources Recommend Favorite

7 Receptor-selective agonists and modes of 7 receptor activation

By Papke R.L.   Meyer E.   Nutter T.   Uteshev V.V.  

European Journal of Pharmacology, Vol. 393, Iss. 1, 2000-03 ,pp. : 179-195

Elsevier

Access to resources Recommend Favorite

Ligand efficacy and affinity in an interacting 7TM receptor model

By Ongun Onaran H.   Gurdal H.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 7, 1999-07 ,pp. : 274-278

Elsevier

Access to resources Recommend Favorite